AXON:NYE-Axovant Sciences Ltd. (USD)

EQUITY | Aerospace & Defense | New York Stock Exchange

Last Closing

USD 296.56

Change

+3.38 (+1.15)%

Market Cap

USD 1.28B

Volume

0.18M

Analyst Target

USD 4.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Axovant Sciences Ltd is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-03 )

Largest Industry Peers for Aerospace & Defense

Symbol Name Price(Change) Market Cap
WWD Woodward Inc

+2.11 (+1.25%)

USD 10.17B
ESLT Elbit Systems Ltd

+0.02 (+0.01%)

USD 8.67B
AVAV AeroVironment Inc

-7.09 (-3.36%)

USD 5.75B
RKLB Rocket Lab USA Inc.

+0.48 (+5.20%)

USD 4.86B
KTOS Kratos Defense & Security Solu..

+0.52 (+2.10%)

USD 3.52B
MRCY Mercury Systems Inc

-0.36 (-0.95%)

USD 2.23B
VSEC VSE Corporation

+0.81 (+0.97%)

USD 1.53B
EH Ehang Holdings Ltd

+0.18 (+1.26%)

USD 0.91B
ATRO Astronics Corporation

+0.15 (+0.77%)

USD 0.69B
SWBI Smith & Wesson Brands Inc

-0.05 (-0.39%)

USD 0.58B

ETFs Containing AXON

XAR SPDR® S&P Aerospace & De.. 4.74 % 0.35 %

+0.33 (+-0.36%)

USD 2.36B
XAD:CA iShares U.S. Aerospace & .. 4.42 % 0.00 %

+0.09 (+-0.36%)

N/A
DFEN Direxion Daily Aerospace .. 3.01 % 1.09 %

+0.06 (+-0.36%)

USD 0.19B
QQQN VictoryShares Nasdaq Next.. 2.90 % 0.00 %

+0.06 (+-0.36%)

USD 0.03B
SAGP The Advisorsa Inner Circl.. 2.25 % 0.00 %

-0.11 (-0.36%)

USD 0.04B
MMSC First Trust Multi-Manager.. 2.06 % 0.00 %

+0.06 (+-0.36%)

USD 0.02B
EQJS:LSE Invesco NASDAQ Next Gener.. 1.94 % 0.00 %

+19.75 (+-0.36%)

USD 0.05B
QQQJ Invesco NASDAQ Next Gen 1.. 1.93 % 0.00 %

+0.15 (+-0.36%)

USD 0.68B
EQQJ:XETRA Invesco NASDAQ Next Gener.. 1.87 % 0.00 %

+0.25 (+-0.36%)

USD 0.05B
TMFX Motley Fool Next Index ET.. 1.69 % 0.00 %

-0.01 (-0.36%)

USD 0.03B
EQQJ:LSE Invesco NASDAQ Next Gener.. 1.55 % 0.00 %

+0.22 (+-0.36%)

N/A
IQCT:LSE Amundi Index Solutions - .. 1.54 % 0.00 %

+0.34 (+-0.36%)

USD 0.07B
RSPN Invesco S&P 500® Equal.. 1.47 % 0.00 %

-0.06 (-0.36%)

USD 0.71B
AMEC:XETRA Amundi Index Solutions - .. 1.43 % 0.00 %

+0.41 (+-0.36%)

USD 9.60M
SCITY:PA 1.43 % 0.00 %

N/A

N/A
SCITY:SW Amundi Index Solutions - .. 1.43 % 0.00 %

-0.58 (-0.36%)

USD 0.07B
QWST 1.36 % 0.00 %

N/A

N/A
IQCY:LSE Amundi Index Solutions - .. 1.25 % 0.00 %

+0.28 (+-0.36%)

N/A
VBK Vanguard Small-Cap Growth.. 1.02 % 0.07 %

+0.76 (+-0.36%)

USD 18.06B
JPSC:XETRA JPMorgan BetaBuilders US .. 0.41 % 0.00 %

+0.09 (+-0.36%)

N/A
IUSF:LSE iShares IV Public Limited.. 0.39 % 0.00 %

+0.38 (+-0.36%)

USD 0.24B
IUSZ:LSE iShares Edge MSCI USA Siz.. 0.39 % 0.00 %

N/A

USD 0.24B
CHEP 0.00 % 1.12 %

N/A

N/A
ITA 0.00 % 0.42 %

N/A

N/A
SCHM Schwab U.S. Mid-Cap ETF 0.00 % 0.05 %

N/A

N/A
VB Vanguard Small-Cap Index .. 0.00 % 0.05 %

+0.01 (+-0.36%)

N/A
BFTR 0.00 % 0.00 %

N/A

N/A
JOET Virtus ETF Trust II 0.00 % 0.00 %

+0.07 (+-0.36%)

USD 0.12B

Market Performance

  Market Performance vs. Industry/Classification (Aerospace & Defense) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.80% 76% C+ 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.80% 76% C+ 79% B-
Trailing 12 Months  
Capital Gain 53.17% 83% B 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.17% 83% B 91% A-
Trailing 5 Years  
Capital Gain 24,208.20% 100% F 99% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 24,208.20% 100% F 99% N/A
Average Annual (5 Year Horizon)  
Capital Gain 19.41% 73% C 79% B-
Dividend Return 19.41% 73% C 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 40.25% 54% F 45% F
Risk Adjusted Return 48.23% 81% B- 78% C+
Market Capitalization 1.28B 100% F 96% N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Aerospace & Defense) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 85.48 13% 12%
Price/Book Ratio 14.55 7% 8%
Price / Cash Flow Ratio 116.90 6% 2%
Price/Free Cash Flow Ratio 117.35 3% 2%
Management Effectiveness  
Return on Equity 16.29% 91% 86%
Return on Invested Capital 8.22% 74% 75%
Return on Assets 2.96% 77% 79%
Debt to Equity Ratio 42.00% 20% 45%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.